ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Tobacco Control Bill Requires Stronger Warnings

August 10, 1990

Nexavar Improves PFS In Phase III Trial

January 25, 2013

NCI Programs: New Grant Programs To Infuse $142 Million Into Tobacco Control Research, Training

November 27, 1998

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992